Skip to main content

Rapid and Near-Patient Tests to Monitor and Guide Therapy in Sickle Cell Disease

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Mar 4, 2016
Award amount: 
$250,000
Organization name: 
BioMedomics, Inc.
Principal Investigator: 
Wang, Frank
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

BioMedomics has developed and begun to market three qualitative diagnostic tests for sickle cell disease, a group of inherited red blood cell disorders. The company is developing a low-cost, rapid, Point of Care test for the quantitative measurement of specific forms of hemoglobin to aid in effective sickle cell treatment decisions. Real time measurements of these clinical markers will both reduce costs and improve patient outcomes.

Fiscal year: 
2016